Dr. Hoffman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave
Chicago, IL 60637Phone+1 888-824-0200Fax+1 773-702-0963
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 1977 - 1980
University of Pennsylvania Health SystemResidency, Internal Medicine, 1973 - 1975
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1972
Certifications & Licensure
IL State Medical License 1977 - 2026
FL State Medical License 2016 - 2021
PA State Medical License 1973 - 2006
GA State Medical License 1975 - 1987- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- Chicago Magazine: Top Doctors Castle Connolly, 2006, 2008, 2010, 2012, 2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- S0002 - A Program to Quit Smoking With or Without Bupropion in Treating Patients With Stage I or II Non-Small Cell Lung Cancer Who Have Undergone Surgery Start of enrollment: 2002 Jan 01
- Dose Escalation of Bevacizumab With Ambulatory Blood Pressure Monitoring in Patients With Advanced Non-squamous NSCLC Start of enrollment: 2010 Mar 01
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsBrief Report: Discordance Between Liquid and Tissue Biopsy-Based Next-Generation Sequencing in Lung Adenocarcinoma at Disease Progression.Misha C Tran, Garth W Strohbehn, Theodore G Karrison, Sherin J Rouhani, Jeremy P Segal
Clinical Lung Cancer. 2023-05-01 - Serving on the FDA oncologic drugs advisory committee.Philip C Hoffman
Clinical Advances in Hematology & Oncology. 2022-11-01 - 53 citationsCDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer.Stanley I. Gutiontov, William Tyler Turchan, Liam F. Spurr, Sherin J. Rouhani, Carolina Soto Chervin
Scientific Reports. 2021-10-08
Press Mentions
'Started Getting a Little Squirrely': What We Heard This WeekFebruary 28th, 2020- First-Line Cyramza in NSCLC Gets Split Decision from FDA PanelFebruary 27th, 2020
- FDA Panel: Thumbs down for Prostate Cancer Focal TherapyFebruary 26th, 2020
- Join now to see all
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
